Preferences help
enabled [disable] Abstract
Number of results
2015 | 87 | 6 | 324-330
Article title

Surgical treatment of gall-bladder cancer

Title variants
Languages of publication
Physical description
1 - 6 - 2015
21 - 1 - 2015
4 - 8 - 2015
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University
  • Department of General, Transplant and Liver Surgery, Warsaw Medical University
  • 1. Wojciechowska U, Didkowska J, Zatoński W: Nowotwory złośliwe w Polsce w 2008 roku. Centrum Onkologii Instytut, Warszawa 2010.
  • 2. Benson AB 3rd, Abrams TA, Ben-Josef E et al.: NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009; 7: 350‑91.
  • 3. Hueman MT, Vollmer Jr CM, Pawlik TM: Evolving Treatment Strategies for Gall-bladder Cancer. Ann Surg Oncol 2009; 16: 2101‑15.
  • 4. Mekeel KL, Hemming AW: Surgical Management of Gall-bladder Carcinoma. A Review. J Gastrointest Surg 2007; 11: 1188‑93.
  • 5. Dai M, Fong M, Lowy A: Treatment of T3 Gallbladder Cancer. J Gastrointest Surg 2009; 13: 2040‑42.
  • 6. Duffy A, CapanuM, Abou-Alfa GK et al.: Gallbladder Cancer (GBC): 10-Year Experience at Memorial Sloan-Kettering Cancer Centre (MSKCC).J Surg Oncol 2008; 98: 485‑89.
  • 7. Miller G, Jarnagin WR: Gall-bladder carcinoma.Eur J Surg Oncol 2008 Mar; 34: 306‑12.
  • 8. Reddy SK, Marroquin CE, Kuo PC et al.: Extended hepatic resection for gall-bladder cancer. Am J Surg 2007; 194: 355‑61.
  • 9. Edge S, Byrd DR, Compton CC et al.: AJCC Cancer Staging Manual 7th ed. 2010, XV, 649 p.
  • 10. Nevin JE, Moran TJ, Kay S et al.: Carcinoma of the gall-bladder: staging, treatment, and prognosis.Cancer 1976; 37: 141‑48.
  • 11. Pawlik TM, Choti MA: Biology Dictates Prognosis Following Resection of Gall-bladder Carcinoma: Sometimes Less is More. Ann Surg Oncol 2009; 16: 787‑88.
  • 12. Barreto SG, Pawar S, Shah S et al.: Patterns of failure and determinants of outcomes following radical re-resection for incidental gall-bladder cancer. World J Surg 2014 Feb; 38(2): 484‑89.
  • 13. Pawlik TM, Gleisner AL, Vigano L et al.: Incidence of finding residual disease for incidental gall-bladder carcinoma: implications for re-resection.J Gastrointest Surg 2007; 11: 1478‑86.
  • 14. D’Angelica M, Dalal KM, DeMatteo RP i wsp.: Analysis of the extent of resection for adenocarci noma of the gall-bladder. Ann Surg Oncol 2009; 16: 806‑16.
  • 15. Kondo S, Hirano S, Tanaka E et al.: Two Types of Extended Liver Resection for Advanced Gall-bladder Cancer: How to Do It. Dig Surg 2011; 28: 148‑53.
  • 16. Birnbaum DJ, Vigan o L, Ferrero A et al.: Locally advanced gall-bladder cancer: Which patients benefit from resection? Eur J Surg Oncol 2013 Nov5. pii: S0748‑7983(13)00862‑7. doi: 10.1016/j.ejso .2013.10.014.
  • 17. Zieniewicz K, Patkowski W: Nowotwory pęcherzyka żółciowego; 245- 249. Chirurgia Dróg Żółciowych i Wątroby (red. Marek Krawczyk). PZWL, Warszawa 2013.
  • 18. Ito H, Ito K, D’Angelica M et al.: Accurate Staging for Gall-bladder Cancer. Implications for Surgical Therapy and Pathological Assessment.Ann Surg 2011; 254: 320‑25.
  • 19. Shuka PJ, Barreto SG: Systematic review: Should routine resection of extra hepatic bile duct be performed in gall-bladder cancer? Saudi J Gastroenterol 2010; 16: 161‑67.
  • 20. Maker AV, Butte JM, Oxenberg J et al.: Is Port Site Resection Necessary in the Surgical Management of Gall-bladder Cancer? Ann Surg Oncol 2012Feb; 19(2): 409‑17.
  • 21. Lee SE, Jang JY, Lim CS et al.: Systematic review on the surgical treatment for T1 gall-bladder cancer. World J Gastroenterol 2011; 17: 174‑80.
  • 22. Cho JY, Han HS, Yoon YS et al.: Laparoscopic Approach for Suspected Early-Stage Gall-bladder Carcinoma. Arch Surg 2010; 145: 128‑33.
  • 23. Gumbs AA, Hoffman JP: Laparoscopic completion radical cholecystectomy for T2 gall-bladder cancer. Surg Endosc 2010; 24: 3221‑23.
  • 24. Kohya N, Kitahara K, Miyazaki K: Rational therapeutic strategy for T2 gall-bladder carcinoma based on tumor spread. World J Gastroenterol 2010; 16: 3567‑72.
  • 25. Engineer R, Wadasadawala T, Mehta S et al.: Chemoradiation for Unresectable Gall-bladder Cancer: Time to Review Historic Nihilism? J Gastrointest Cancer 2011; 42: 222‑27.
  • 26. Jarnagin WR, Ruo L, Little SA et al.: Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.Cancer 2003; 98: 1689‑700
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.